Publications: Dr David Gould
Alostath H, Chatzopoulou D, Holmes S, Stephen A, Gould D, Sukhorukov G, Cattell M
(
2024
)
.
OR069 A NOVEL COATING ONTO LEONARD BUTTONS; SURGICAL SITE INFECTION PREVENTION IN MANDIBULAR FRACTURES
.
International Journal of Oral and Maxillofacial Surgery
vol.
52
,
Cattell M, Chatzopoulou D, Hawraa A, Gould D, Sukhorukov G, Holmes S
(
2023
)
.
Synthesis of Novel Antimicrobial CHX-CaCl2 Coatings on Maxillofacial Fixatures for Infection Prevention
.
International Journal of Molecular Sciences
vol.
24
,
(
12
)
1
-
12
.
Kudryavtseva V, Otero M, Zhang J, Bukatin A, Gould D, Sukhorukov GB
(
2023
)
.
Drug-Eluting Sandwich Hydrogel Lenses Based on Microchamber Film Drug Encapsulation
.
ACS Nanoscience Au
vol.
3
,
(
3
)
256
-
265
.
Bystrom J, Taher TE, Henson SM, Gould DJ, Mageed RA
(
2022
)
.
Metabolic requirements of Th17 cells and of B cells: Regulation and defects in health and in inflammatory diseases
.
Frontiers in Immunology
vol.
13
,
Khan AN, Ermakov A, Saunders T, Giddens H, Gould D, Sukhorukov G, Hao Y
(
2022
)
.
Electrical characterization of micron sized chambers used as a depot for drug delivery
.
IEEE Sensors Journal
Kudryavtseva V, Bukatin A, Vyacheslavova E, Gould D, Sukhorukov GB
(
2022
)
.
Printed asymmetric microcapsules: Facile loading and multiple stimuli-responsiveness
.
Biomaterials Advances
vol.
136
,
Riveiro ME, Frapolli R, Taraboletti GTG, Rezai K, Meroni M, Russo M, Borsotti P, Schultz C et al.
(
2021
)
.
Abstract 916: A novel LAP-IL2 fusion protein elicits efficacy as single agent in syngeneic renal and melanoma mouse models
.
Cancer Research
vol.
81
,
(
13_Supplement
)
916
-
916
.
Kudryavtseva V, Boi S, Read J, Gould D, Szewczyk PK, Stachewicz U, Kiryukhin MV, Pastorino L et al.
(
2021
)
.
Micro-sized "pelmeni" - A universal microencapsulation approach overview
.
Materials & Design
vol.
202
,
Kudryavtseva V, Boi S, Read J, Guillemet R, Zhang J, Udalov A, Shesterikov E, Tverdokhlebov S et al.
(
2021
)
.
Biodegradable Defined Shaped Printed Polymer Microcapsules for Drug Delivery
.
ACS Applied Materials & Interfaces
vol.
13
,
(
2
)
2371
-
2381
.
Riveiro ME, Frapolli R, Taraboletti GTG, Rezai K, Meroni M, Russo M, Borsotti P, Schultz C et al.
(
2021
)
.
A novel LAP-IL2 fusion protein elicits efficacy as single agent in syngeneic renal and melanoma mouse models
.
CANCER RESEARCH
.
vol.
81
,
Young ER, Gould DJ, Hart SL
(
2021
)
.
Delivery of disease-responsive mini-intronic plasmids with cationic liposome vectors for rheumatoid arthritis
.
HUMAN GENE THERAPY
.
vol.
32
,
A132
-
A132
.
Young ER, Nikolaenko V, Heywood W, Gould DJ, Hart SL
(
2021
)
.
Design and Optimisation of Synovial-Targeted Non-Viral Lipid Nanoparticles for Systemic Delivery in Rheumatoid Arthritis
.
MOLECULAR THERAPY
.
vol.
29
,
228
-
228
.
Sindeeva OA, Kopach O, Kurochkin MA, Sapelkin A, Gould DJ, Rusakov DA, Sukhorukov GB
(
2020
)
.
Polylactic Acid-Based Patterned Matrixes for Site-Specific Delivery of Neuropeptides On-Demand: Functional NGF Effects on Human Neuronal Cells
.
Frontiers in Bioengineering and Biotechnology
vol.
8
,
Young E, Gould D, Hart S
(
2020
)
.
Toward gene therapy in rheumatoid arthritis
.
Expert Review of Precision Medicine and Drug Development1
-
11
.
Read JE, Luo D, Chowdhury TT, Flower RJ, Poston RN, Sukhorukov GB, Gould DJ
(
2020
)
.
Magnetically responsive layer-by-layer microcapsules can be retained in cells and under flow conditions to promote local drug release without triggering ROS production
.
Nanoscale
vol.
12
,
(
14
)
7735
-
7748
.
Young E, Gould DJ, Hart SL
(
2020
)
.
Targeted Non-Viral Delivery of Mini-Intronic Plasmids for Rheumatoid Arthritis
.
MOLECULAR THERAPY
.
vol.
28
,
471
-
471
.
Luo D, Poston RN, Gould DJ, Sukhorukov GB
(
2018
)
.
Magnetically targetable microcapsules display subtle changes in permeability and drug release in response to a biologically compatible low frequency alternating magnetic field
.
Materials Science and Engineering C
vol.
94
,
647
-
655
.
Popov AL, Popova N, Gould DJ, Shcherbakov AB, Sukhorukov GB, Ivanov VK
(
2018
)
.
Ceria Nanoparticles-Decorated Microcapsules as a Smart Drug Delivery/Protective System: Protection of Encapsulated P. pyralis Luciferase
.
ACS Appl Mater Interfaces
vol.
10
,
(
17
)
14367
-
14377
.
Gai M, Kurochkin MA, Li D, Khlebtsov BN, Dong L, Tarakina N, Poston R, Gould DJ et al.
(
2018
)
.
In-situ NIR-laser mediated bioactive substance delivery to single cell for EGFP expression based on biocompatible microchamber-arrays
.
J Control Release
vol.
276
,
84
-
92
.
Yousaf N, Gould D
(
2017
)
.
Demonstrating Interactions of Transcription Factors with DNA by Electrophoretic Mobility Shift Assay
.
Mammalian Synthetic Promoters
,
vol.
1651
,
Springer Nature
Gould D
(
2017
)
.
Initial Considerations Before Designing a Promoter Construct
.
Mammalian Synthetic Promoters
,
vol.
1651
,
Springer Nature
Gould D
(
2017
)
.
Mammalian Synthetic Promoters
.
Humana Press
Mohamed H, Gould D
(
2017
)
.
PCR Assembly of Synthetic Promoters
.
Mammalian Synthetic Promoters
,
vol.
1651
,
Springer Nature
Yousaf N, Gould D
(
2017
)
.
The Tetracycline Responsive System
.
Springer Nature
Timin AS, Gould DJ, Sukhorukov GB
(
2017
)
.
Multi-layer microcapsules: fresh insights and new applications
.
Expert Opin Drug Deliv
vol.
14
,
(
5
)
583
-
587
.
Schultz CMA, Mullen L, Gould DJ, Chernajovsky Y
(
2017
)
.
Progranulin and derivatives can be employed as latent dual-function chondrogenic and anti-inflammatory therapeutics for the treatment of arthritis
.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
.
vol.
98
,
A11
-
A11
.
CATTELL MJ, Sukhorukov G, Gould DJ, shahid S, Zhang, X, Luo DONG
(
2016
)
.
Electrospun poly (lactic acid) fibers containing novel chlorhexidine particles with sustained antibacterial activity
.
Biomaterials Science
Svenskaya YI, Pavlov AM, Gorin DA, Gould DJ, Parakhonskiy BV, Sukhorukov GB
(
2016
)
.
Photodynamic therapy platform based on localized delivery of photosensitizer by vaterite submicron particles
.
Colloids Surf B Biointerfaces
vol.
146
,
171
-
179
.
Mohamed H, Chernajovsky Y, Gould D
(
2016
)
.
Assembly PCR synthesis of optimally designed, compact, multi-responsive promoters suited to gene therapy application
.
Scientific Reports
vol.
6
,
29388
-
29388
.
Luo D, Gould DJ, Sukhorukov GB
(
2016
)
.
Local and Sustained Activity of Doxycycline Delivered with Layer-by-Layer Microcapsules
.
Biomacromolecules
vol.
17
,
(
4
)
1466
-
1476
.
Subang MC, Fatah R, Wu Y, Hannaman D, Rice J, Evans CF, Chernajovsky Y, Gould D
(
2015
)
.
Effects of APC De-Targeting and GAr Modification on the Duration of Luciferase Expression from Plasmid DNA Delivered to Skeletal Muscle
.
Current Gene Therapy
vol.
15
,
(
1
)
3
-
14
.
Pavlov AM, Gabriel SA, Sukhorukov GB, Gould DJ
(
2015
)
.
Improved and targeted delivery of bioactive molecules to cells with magnetic layer-by-layer assembled microcapsules
.
Nanoscale
vol.
7
,
(
21
)
9686
-
9693
.
Mullen L, Adams G, Foster J, Vessillier S, Köster M, Hauser H, Layward L, Gould D et al.
(
2014
)
.
A comparative study of matrix metalloproteinase and aggrecanase mediated release of latent cytokines at arthritic joints
.
Ann Rheum Dis
vol.
73
,
(
9
)
1728
-
1736
.
(
2014
)
.
Identification of ZDHHC14 as a novel human tumour suppressor gene. J Pathol 2014; 232: 566–577
.
The Journal of Pathology
vol.
234
,
(
1
)
134
-
134
.
(
2014
)
.
Errata
.
The FASEB Journal
vol.
28
,
(
6
)
2737
-
2737
.
Yeste-Velasco M, Mao X, Grose R, Kudahetti SC, Lin D, Marzec J, Vasiljević N, Chaplin T et al.
(
2014
)
.
Identification of ZDHHC14 as a novel human tumour suppressor gene
.
J Pathol
vol.
232
,
(
5
)
566
-
577
.
Muhammad H, Taher T, Mullen L, Pastan I, Marshall J, Chernajovsky Y, Gould D, Mageed R
(
2014
)
.
Development of a novel approach for targeted delivery of siRNA to B lymphocytes with a potential application in cancer
.
HUMAN GENE THERAPY
.
vol.
25
,
A5
-
A5
.
Mohamed H, Chernajovsky Y, Gould D
(
2014
)
.
Development of novel transcriptionally responsive synthetic promoters for therapeutic gene expression during disease activity
.
HUMAN GENE THERAPY
.
vol.
25
,
A8
-
A8
.
Koutsokeras A, Purkayastha N, Rigby A, Subang MC, Sclanders M, Vessillier S, Mullen L, Chernajovsky Y et al.
(
2014
)
.
Generation of an efficiently secreted, cell penetrating NF-κB inhibitor
.
FASEB J
vol.
28
,
(
1
)
373
-
381
.
Yeste-Velasco M, Mao X, Grose R, Kudahetti SC, Marzec J, Vasiljevic N, Chaplin T, Foster JM et al.
(
2014
)
.
Identification of <i>ZDHHC14</i> as a novel human tumour suppressor: gene
.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
vol.
34
,
S90
-
S90
.
Mullen L, Rigby A, Sclanders M, Adams G, Mittal G, Colston J, Fatah R, Subang C et al.
(
2014
)
.
Latency can be conferred to a variety of cytokines by fusion with latency-associated peptide from TGF-β
.
Expert Opin Drug Deliv
vol.
11
,
(
1
)
5
-
16
.
Mullen L, Adams G, Layward L, Vessillier S, Annenkov A, Mittal G, Rigby A, Sclanders M et al.
(
2014
)
.
Latent cytokines for targeted therapy of inflammatory disorders
.
Expert Opin Drug Deliv
vol.
11
,
(
1
)
101
-
110
.
Pavlov AM, Sukhorukov GB, Gould DJ
(
2013
)
.
Location of molecules in layer-by-layer assembled microcapsules influences activity, cell delivery and susceptibility to enzyme degradation
.
J Control Release
vol.
172
,
(
1
)
22
-
29
.
Gould D
(
2013
)
.
Gene doping: gene delivery for olympic victory
.
Br J Clin Pharmacol
vol.
76
,
(
2
)
292
-
298
.
Viale DL, Cafferata EG, Gould D, Rotondaro C, Chernajovsky Y, Curiel DT, Podhajcer OL, Lopez MV
(
2013
)
.
Therapeutic Improvement of a Stroma-Targeted CRAd by Incorporating Motives Responsive to the Melanoma Microenvironment
.
Journal of Investigative Dermatology
vol.
133
,
(
11
)
2576
-
2584
.
Pavlov AM, Sukhorukov GB, Gould DJ
(
2013
)
.
Lessons in microcapsule assembly from imaging delivery of a bioluminescent enzyme
.
Biomacromolecules
vol.
14
,
(
3
)
608
-
612
.
CHERNAJOVSKY Y, Mullen L, Vessillier S, Rigby A, Gould DJ, Fatah R, Adams G, Koutsokeras A et al.
(
2013
)
.
Development of latent cytokine fusion proteins
.
Fusion protein technologies for biopharmaceuticals: Applications and Challenges
,
Editors:
Schmidt, S
,
Wiley and Blackwell
Mohamed H, Chernajovsky Y, Gould D
(
2013
)
.
Development of novel transciptionally responsive synthetic promoters for therapeutic gene expression during disease activity
.
HUMAN GENE THERAPY
.
vol.
24
,
A36
-
A36
.
Muhammad H, Taher T, Mullen L, Pastan I, Chernajovsky Y, Gould D, Mageed R
(
2013
)
.
Generation of a secreted scFv for specific delivery of siRNA to B-lymphocytes
.
HUMAN GENE THERAPY
.
vol.
24
,
A36
-
A36
.
Chernajovsky Y, Annenkov A, Herman C, Triantaphyllopoulos K, Gould D, Dreja H, Moyes SP, Croxford JL et al.
(
2012
)
.
Gene Therapy for Rheumatoid Arthritis
.
Drugs & Aging
vol.
12
,
(
1
)
29
-
41
.
Leinster DA, Kulbe H, Everitt G, Thompson R, Perretti M, Gavins FNE, Cooper D, Gould D et al.
(
2012
)
.
The peritoneal tumour microenvironment of high-grade serous ovarian cancer
.
J Pathol
vol.
227
,
(
2
)
136
-
145
.
Yeste-Velasco M, Mao X, Grose R, Kudahetti SC, Lin D, Chaplin T, Xue L, Xu M et al.
(
2012
)
.
Abstract 4858: Identification of ZDHHC14 as a novel tumor suppressor gene commonly downregulated in human cancers
.
Cancer Research
vol.
72
,
(
8_Supplement
)
4858
-
4858
.
Subang MC, Fatah R, Bright C, Blanco P, Berenstein M, Wu Y, Podhajcer OL, Winyard PG et al.
(
2012
)
.
A novel hybrid promoter responsive to pathophysiological and pharmacological regulation
.
J Mol Med (Berl)
vol.
90
,
(
4
)
401
-
411
.
Hughes C, Faurholm B, Dell'Accio F, Manzo A, Seed M, Eltawil N, Marrelli A, Gould D et al.
(
2011
)
.
TARGETING THERAPEUTICS TO ARTHRITIC JOINTS
.
RHEUMATOLOGY
.
vol.
50
,
127
-
127
.
Battery L, Solomon A, Gould D
(
2011
)
.
Gene Doping: Olympic Genes for Olympic Dreams
.
J R Soc Med
vol.
104
,
494
-
500
.
Stok KS, Noel D, Apparailly F, Gould D, Chernajovsky Y, Jorgensen C, Muller R
(
2010
)
.
Quantitative imaging of cartilage and bone for functional assessment of gene therapy approaches in experimental arthritis
.
J TISSUE ENG REGEN M
vol.
4
,
(
5
)
387
-
394
.
Hughes C, Faurholm B, Dell'Accio F, Manzo A, Seed M, Eltawil N, Marrelli A, Gould D et al.
(
2010
)
.
Human single-chain variable fragment that specifically targets arthritic cartilage
.
Arthritis Rheum
vol.
62
,
(
4
)
1007
-
1016
.
Subang MC, Gould D
(
2010
)
.
Delivery and application of Plasmid DNA in Arthritis Gene Therapy
.
Gene Therapy for Autoimmune and Inflammatory diseases’ Milestones in Drug Therapy
,
Editors:
Chernajovsky, Y, Robbins, PD
,
BIRKHAUSER
Vilalta M, Jorgensen C, Degano IR, Chernajovsky Y, Gould D, Noel D, Andrades JA, Becerra J et al.
(
2009
)
.
Dual luciferase labelling for non-invasive bioluminescence imaging of mesenchymal stromal cell chondrogenic differentiation in demineralized bone matrix scaffolds
.
BIOMATERIALS
vol.
30
,
(
28
)
4986
-
4995
.
Jawad AS, Taher TE, Rahim A, D'Acquisto F, Gould D, Mageed RA
(
2009
)
.
SELECTIVE TARGETING OF THE CANONICAL OR ALTERNATIVE NF-kappa B PATHWAY REVEALS NEW INSIGHTS INTO MECHANISMS OF B-LYMPHOCYTE SURVIVAL AND SELECTION
.
RHEUMATOLOGY
.
vol.
48
,
I30
-
I31
.
Lopez MV, Viale DL DL, Cafferata EG, Bravo AI, Carbone C, Gould D, Chernajovsky Y, Podhajcer OL
(
2009
)
.
Tumor associated stromal cells play a critical role on the outcome of the oncolytic efficacy of conditionally replicative adenoviruses
.
PLoS ONE
vol.
4
,
Vilalta M, Degano IR, Bago J, Gould D, Santos M, Garcia-Arranz M, Ayats R, Fuster C et al.
(
2008
)
.
Biodistribution, Long-term Survival, and Safety of Human Adipose Tissue-derived Mesenchymal Stem Cells Transplanted in Nude Mice by High Sensitivity Non-invasive Bioluminescence Imaging
.
STEM CELLS DEV
vol.
17
,
(
5
)
993
-
1003
.
Taher TE, Tulone C, Fatah R, D'Acquisto F, Gould DJ, Mageed RA
(
2008
)
.
Repopulation of B-lymphocytes with restricted gene expression using haematopoietic stem cells engineered with lentiviral vectors
.
Gene Ther
vol.
15
,
(
13
)
998
-
1006
.
Subang MC, Fatah R, Wu Y, Chernajovsky Y, Gould DJ
(
2008
)
.
Progress with the delivery of biologic molecules by gene therapy in arthritis using plasmid DNA
.
HUMAN GENE THERAPY
.
vol.
19
,
418
-
418
.
Subang MC, Rice J, Fatah R, Wu Y, Chernajovsky Y, Gould DJ
(
2008
)
.
Strategies to prevent immunogenicity of foreign intracellular proteins
.
HUMAN GENE THERAPY
.
vol.
19
,
421
-
421
.
Gould DJ, Chernajovsky Y
(
2007
)
.
Novel delivery methods to achieve immunomodulation
.
Curr Opin Pharmacol
vol.
7
,
(
4
)
445
-
450
.
Khoury M, Adriaansen J, Vervoordeldonk MJBM, Gould D, Chernajovsky Y, Bigey P, Bloquel C, Scherman D et al.
(
2007
)
.
Inflammation-inducible anti-TNF gene expression mediated by intra-articular injection of serotype 5 adeno-associated virus reduces arthritis
.
J GENE MED
vol.
9
,
(
7
)
596
-
604
.
Khoury M, Adriaansen J, Vervoordeldonk MJBM, Gould D, Chernajovsky Y, Bigey P, Bloquel C, Scherman D et al.
(
2007
)
.
Inflammation-inducible anti-TNF gene expression by intra-articular injection of serotype 5 adeno-associated virus reduces arthritis
.
ANNALS OF THE RHEUMATIC DISEASES
.
vol.
66
,
A56
-
A56
.
Kulbe H, Thompson R, Wilson JL, Robinson S, Hagemann T, Fatah R, Gould D, Ayhan A et al.
(
2007
)
.
The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells
.
CANCER RES
vol.
67
,
(
2
)
585
-
592
.
Gould D, Yousaf N, Fatah R, Subang MC, Chernajovsky Y
(
2007
)
.
Gene therapy with an improved doxycycline-regulated plasmid encoding a tumour necrosis factor-alpha inhibitor in experimental arthritis
.
ARTHRITIS RES THER
vol.
9
,
(
1
)
Article
R7
,
Adriaansen J, Khoury M, de Cortie CJ, Fallaux FJ, Bigey P, Scherman D, Gould D, Chernajovsky Y et al.
(
2007
)
.
Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF blocking agent
.
Ann Rheum Dis
vol.
66
,
1143
-
1150
.
Lopez MV, Blanco P, Viale DL, Cafferata EG, Carbone C, Gould D, Chernajovsky Y, Podhajcer OL
(
2006
)
.
Expression of a suicidal gene under control of the human secreted protein acidic and rich in cysteine (SPARC) promoter in tumor or stromal cells led to the inhibition of tumor cell growth
.
MOL CANCER THER
vol.
5
,
(
10
)
2503
-
2511
.
CHERNAJOVSKY Y, Gould D, Podhajcer OL, Cafferata EA, Carbone C, Viale D, Blanco P, Lopez MV
(
2006
)
.
Expression of suicidal gene under control of the human SPARC promoter in tumor or stromal cells led to the inhibition of tumor cell growth
.
Mol. Cancer Ther.
vol.
5
,
(
10
)
2503
-
2511
.
Adriaansen J, Khoury M, de Cortie K, Bigey P, Sherman D, Gould D, Chernajovsky Y, Jorgensen C et al.
(
2006
)
.
Suppression of inflammation following intra-articular gene therapy with recombinant AAV5-Chimeric TNFR-Ig vector under an inducible promoter in animal models of rheumatoid arthritis
.
ARTHRITIS AND RHEUMATISM
.
vol.
54
,
S176
-
S177
.
Lopez MV, Viale D, Cafferata EG, Macio DR, Gould D, Chernajovsky Y, Podhajcer OL
(
2006
)
.
777. A Novel Pan-Oncolytic Adenovirus Therapeutically Effective in Different Cancer Cell Types
.
Molecular Therapy
.
vol.
13
,
s300
-
s301
.
Khoury M, Adriaansen J, Louis-Plence P, Noel D, Bigey P, de Cortie C, Gould D, Vervoordeldonk M et al.
(
2006
)
.
Amelioration of Arthritis after Local Delivery of an Adeno-Associated Virus Type 6 Expressing a TNF-Blocking Agent under a Disease-Inducible Promoter
.
MOLECULAR THERAPY
vol.
13
,
S409
-
S409
.
Hagemann T, GOULD DJ, Wilson J, Fatah R, Robinson S, Kulbe H, Thompson R, Blakwill F et al.
(
2006
)
.
The inflammatory cytokine TNF-á generates an autocrine tumor- promoting network in epithelial ovarian cancer cells
.
Cancer Res
Yousaf N, Gould DJ, Aganna E, Hammond L, Mirakian RM, Turner MD, Hitman GA, McDermott MF et al.
(
2005
)
.
Tumor necrosis factor receptor I from patients with tumor necrosis factor receptor-associated periodic syndrome interacts with wild-type tumor necrosis factor receptor I and induces ligand-independent NF-kappaB activation
.
Arthritis Rheum
vol.
52
,
(
9
)
2906
-
2916
.
Chernajovsky Y, Gould DJ, Podhajcer OL
(
2004
)
.
Gene therapy for autoimmune diseases: quo vadis?
.
Nat Rev Immunol
vol.
4
,
(
10
)
800
-
811
.
Gould DJ, Chernajovsky Y
(
2004
)
.
Endogenous GATA factors bind the core sequence of the tetO and influence gene regulation with the tetracycline system
.
Mol Ther
vol.
10
,
(
1
)
127
-
138
.
Gould DJ, Chernajovsky Y
(
2004
)
.
Application of regulatable vectors in gene therapy of experimental arthritis
.
ARTHRITIS RESEARCH & THERAPY
.
vol.
6
,
S27
-
S27
.
CHERNAJOVSKY Y, Gould DJ, Podhajcer OL
(
2004
)
.
Genetic Interventions for the treatment of autoimmune diseases: Quo Vadis?
.
Nat Rev Immunol
vol.
4
,
(
10
)
800
-
811
.
Gould DJ, Bright C, Chernajovsky Y
(
2004
)
.
Inhibition of established collagen-induced arthritis with a tumour necrosis factor-alpha inhibitor expressed from a self-contained doxycycline regulated plasmid
.
Arthritis Res Ther
vol.
6
,
(
2
)
R103
-
R113
.
Chernajovsky Y, Vessillier S, Adams G, Gofur Y, Subang MC, Annenkov A, Favorov P, Daly G et al.
(
2003
)
.
Development of new molecules, vectors and cells for therapy of arthritis
.
JOINT BONE SPINE
vol.
70
,
(
6
)
474
-
476
.
Chernajovsky Y, Vessillier S, Adams G, Gofur Y, Subang MC, Annenkov A, Favorov P, Daly G et al.
(
2003
)
.
Développement de nouvelles molécules, vecteurs et cellules thérapeutiques dans les arthrites
.
Revue du Rhumatisme
vol.
70
,
(
10-11
)
846
-
848
.
Gould DJ, Favorov P
(
2003
)
.
Vectors for the treatment of autoimmune disease
.
GENE THER
vol.
10
,
(
10
)
912
-
927
.
CHERNAJOVSKY Y, Gould D, Dreja H, Triantaphyllopoulos K
(
2003
)
.
Interferon-beta gene therapy for the treatment of arthritis
.
Methods Mol Biol.
vol.
215
,
171
-
180
.
Chernajovsky Y, Dreja H, Triantaphyllopoulos K, Gould D
(
2003
)
.
Interferon-β Gene Therapy for the Treatment of Arthritis
.
Cytokines and Colony Stimulating Factors
,
vol.
215
,
Springer Nature
Gould DJ
(
2002
)
.
Inducible diabetes and transgene expression in a single mouse: a tool to elucidate autoimmune mechanisms
.
TRANSGENIC RES
vol.
11
,
(
6
)
583
-
585
.
Dai L, O'Shaughnessy MC, Gould D, Claxson A, Marklund S, Kidd B, Chernajovsky Y, Winyard PG
(
2002
)
.
SUPPRESSION OF INFLAMMATION BY ANTIOXIDANT GENE THERAPY IN AN ANTIGEN-INDUCED ARTHRITIS MODEL
.
RHEUMATOLOGY
vol.
41
,
34
-
34
.
Gould D
(
2001
)
.
Targeted arthritis gene therapy with T cells
.
Arthritis Research & Therapy
vol.
3
,
(
1
)
Gould DJ, Berenstein M, Dreja H, Ledda F, Podhajcer OL, Chernajovsky Y
(
2000
)
.
A novel doxycycline inducible autoregulatory plasmid which displays 'on'/'off' regulation suited to gene therapy applications
.
GENE THER
vol.
7
,
(
24
)
2061
-
2070
.
Chernajovsky Y, Dreja H, Daly G, Annenkov A, Gould D, Adams G, Croxford JL, Baker D et al.
(
2000
)
.
Immuno- and genetic therapy in autoimmune diseases
.
Genes Immun
vol.
1
,
(
5
)
295
-
307
.
Chernajovsky Y, Gould D, Annenkov A, Dreja H, Daly G, Rabinovich GA, Croxford L, Baker D et al.
(
1999
)
.
Immunotherapy of auto-immune diseases by gene transfer
.
Biochem Soc Trans
vol.
27
,
(
6
)
869
-
873
.
Chernajovsky Y, Gould D, Annenkov A, Dreja H, Daly G, Rabinovich GA, Croxford L, Baker D et al.
(
1999
)
.
IMMUNOTHERAPY OF AUTOIMMUNE DISEASES BY GENE TRANSFER
.
Biochemical Society Transactions
vol.
27
,
(
5
)
a137
-
a137
.